CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy-Reference-Cited by-同舟云学术

CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy

Published:2017-06-06 Issue:2 Volume:99 Page:186-189
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Minarik Jiri¹^ORCID,Novak Martin¹,Flodr Patrik²,Balcarkova Jana¹,Mlynarcikova Miroslava¹,Krhovska Petra¹,Pika Tomas¹,Pikalova Zuzana¹,Bacovsky Jaroslav¹,Scudla Vlastimil¹

Affiliation:

1. Department of Hemato-Oncology; Faculty of Medicine and Dentistry; Palacky University Olomouc and University Hospital Olomouc; Olomouc Czech Republic

2. Department of Clinical and Molecular Pathology; Faculty of Medicine and Dentistry; Palacky University Olomouc and University Hospital Olomouc; Olomouc Czech Republic

Funder

Internal Grant Agency

Agency of Health

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12902/fullpdf

Reference19 articles.

1. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management;Rajkumar;Am J Hematol,2016

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014